HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipocalin-type prostaglandin D synthase (beta-trace) in cerebrospinal fluid: a useful marker for the diagnosis of normal pressure hydrocephalus.

Abstract
Lipocalin-type prostaglandin D synthase (PGDS) is considered to be mainly produced in the leptomeninges and secreted into cerebrospinal fluid (CSF). We found PGDS levels in CSF of patients with normal pressure hydrocephalus (NPH) (8.99+/-2.59 microg/ml, mean+/-S.D., n=14) to be significantly lower than levels in a control (15.29+/-5.17, n=14, P<0.0001) and other dementia group (19.14+/-4.34, n=7, P=0.0003). Thus, PGDS level in CSF is a useful marker for the differential diagnosis of NPH from other diseases with dementia.
AuthorsMitsuhito Mase, Kazuo Yamada, Naoki Shimazu, Kosuke Seiki, Hiroshi Oda, Hiroya Nakau, Takashi Inui, Weidong Li, Naomi Eguchi, Yoshihiro Urade
JournalNeuroscience research (Neurosci Res) Vol. 47 Issue 4 Pg. 455-9 (Dec 2003) ISSN: 0168-0102 [Print] Ireland
PMID14630351 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Lipocalins
  • Intramolecular Oxidoreductases
  • prostaglandin R2 D-isomerase
Topics
  • Aged
  • Aged, 80 and over
  • Biomarkers (cerebrospinal fluid)
  • Dementia (cerebrospinal fluid)
  • Diagnosis, Differential
  • Female
  • Humans
  • Hydrocephalus, Normal Pressure (cerebrospinal fluid)
  • Intramolecular Oxidoreductases (cerebrospinal fluid)
  • Lipocalins
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: